The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Giuseppe Toffoli

Experimental and Clinical Pharmacology Unit

Centro di Riferimento Oncologico National Cancer Institute

via Pedemontana Occidentale 12

Aviano 33081



Name/email consistency: high



  • Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico National Cancer Institute, via Pedemontana Occidentale 12, Aviano 33081, Italy. 2003 - 2010


  1. Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer. Toffoli, G., Cecchin, E., Gasparini, G., D'Andrea, M., Azzarello, G., Basso, U., Mini, E., Pessa, S., De Mattia, E., Lo Re, G., Buonadonna, A., Nobili, S., De Paoli, P., Innocenti, F. J. Clin. Oncol. (2010) [Pubmed]
  2. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Toffoli, G., Biason, P., Russo, A., De Mattia, E., Cecchin, E., Hattinger, C.M., Pasello, M., Alberghini, M., Ferrari, C., Scotlandi, K., Picci, P., Serra, M. Clin. Cancer Res. (2009) [Pubmed]
  3. Pharmacogenetic relevance of MTHFR polymorphisms. Toffoli, G., De Mattia, E. Pharmacogenomics (2008) [Pubmed]
  4. Pharmacology of epidermal growth factor inhibitors. Toffoli, G., De Mattia, E., Cecchin, E., Biason, P., Masier, S., Corona, G. Int. J. Biol. Markers (2007) [Pubmed]
  5. Pharmacogenetics and stomach cancer: an update. Toffoli, G., Cecchin, E. Pharmacogenomics (2007) [Pubmed]
  6. Clinical implications of genetic polymorphisms on stomach cancer drug therapy. Toffoli, G., Cecchin, E. Pharmacogenomics J. (2007) [Pubmed]
  7. The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer. Toffoli, G., Cecchin, E., Corona, G., Russo, A., Buonadonna, A., D'Andrea, M., Pasetto, L.M., Pessa, S., Errante, D., De Pangher, V., Giusto, M., Medici, M., Gaion, F., Sandri, P., Galligioni, E., Bonura, S., Boccalon, M., Biason, P., Frustaci, S. J. Clin. Oncol. (2006) [Pubmed]
  8. Pharmacokinetic optimisation of treatment with oral etoposide. Toffoli, G., Corona, G., Basso, B., Boiocchi, M. Clin. Pharmacokinet (2004) [Pubmed]
  9. Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin. Toffoli, G., Sorio, R., Basso, B., Aita, P., Corona, G., Rupolo, M., Ruolo, G., Boiocchi, M. J. Chemother (2004) [Pubmed]
  10. Pharmacogenomics and stomach cancer. Toffoli, G., Cecchin, E. Pharmacogenomics (2004) [Pubmed]
  11. Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma. Toffoli, G., Corona, G., Cattarossi, G., Boiocchi, M., Di Gennaro, G., Tirelli, U., Vaccher, E. Ann. Oncol. (2004) [Pubmed]
  12. Uridine diphosphoglucuronosyl transferase and methylenetetrahydrofolate reductase polymorphisms as genomic predictors of toxicity and response to irinotecan-, antifolate- and fluoropyrimidine-based chemotherapy. Toffoli, G., Cecchin, E. J. Chemother (2004) [Pubmed]
  13. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Toffoli, G., Russo, A., Innocenti, F., Corona, G., Tumolo, S., Sartor, F., Mini, E., Boiocchi, M. Int. J. Cancer (2003) [Pubmed]
  14. Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north Italy. Toffoli, G., Gafà, R., Russo, A., Lanza, G., Dolcetti, R., Sartor, F., Libra, M., Viel, A., Boiocchi, M. Clin. Cancer Res. (2003) [Pubmed]
  15. Pharmacogenetics of irinotecan. Toffoli, G., Cecchin, E., Corona, G., Boiocchi, M. Curr. Med. Chem. Anticancer. Agents (2003) [Pubmed]
  16. Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase. Toffoli, G., Rossi, D., Gaidano, G., Cecchin, E., Boiocchi, M., Carbone, A. Int. J. Biol. Markers (2003) [Pubmed]
WikiGenes - Universities